Patents by Inventor Linda K. Myers

Linda K. Myers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • APLs for treating arthritis
    Patent number: 9144595
    Abstract: One embodiment of a therapeutic composition comprises one or more APLs, e.g., APL A12, for treating diseases or disorders related to arthritis, including rheumatoid arthritis. Another embodiment includes a method of inducing a Th2-type cytokine secretion profile in a mammal, including administering a therapeutic amount of A12 analog peptide. Another embodiment includes a method for generating functional T regulatory cells, the method including administering a therapeutic amount of APL A12 to a RA patient.
    Type: Grant
    Filed: October 1, 2013
    Date of Patent: September 29, 2015
    Assignee: University of Tennessee Research Foundation
    Inventors: Arnold E. Postlethwaite, Andrew Ho Kang, Linda K. Myers
  • APLS FOR TREATING ARTHRITIS
    Publication number: 20140113867
    Abstract: One embodiment of a therapeutic composition comprises one or more APLs, e.g., APL A12, for treating diseases or disorders related to arthritis, including rheumatoid arthritis. Another embodiment includes a method of inducing a Th2-type cytokine secretion profile in a mammal, including administering a therapeutic amount of A12 analog peptide. Another embodiment includes a method for generating functional T regulatory cells, the method including administering a therapeutic amount of APL A12 to a RA patient.
    Type: Application
    Filed: October 1, 2013
    Publication date: April 24, 2014
    Inventors: Arnold E. Postlethwaite, Andrew Ho Kang, Linda K. Myers
  • APLS FOR TREATING ARTHRITIS
    Publication number: 20110195905
    Abstract: One embodiment of a therapeutic composition comprises one or more APLs, e.g., APL A12, for treating diseases or disorders related to arthritis, including rheumatoid arthritis. Another embodiment includes a method of inducing a Th2-type cytokine secretion profile in a mammal, including administering a therapeutic amount of A12 analog peptide. Another embodiment includes a method for generating functional T regulatory cells, the method including administering a therapeutic amount of APL A12 to a RA patient.
    Type: Application
    Filed: October 28, 2010
    Publication date: August 11, 2011
    Applicant: arGentis Pharmaceuticals, LLC
    Inventors: Arnold R. Postlewaite, Andrew H. Kang, Linda K. Myers
  • Synthetic peptide for treatment of autoimmune arthritis
    Patent number: 6423315
    Abstract: Peptides that are capable of suppressing autoimmune arthritis are disclosed. The polypeptides described by the present invention which are capable of suppressing autoimmune arthritis in mammals include analogues of CII 245-270. The peptides do not provoke a material immunogenic response from T cells, and thus are useful therapeutic agents for suppressing autoimmune arthritis, rheumatoid arthritis, juvenile arthritis, psoriatic arthritis, spondylo arthritis, relapsing polychondritis and other connective tissue diseases. A method of surpressing autoimmune arthritis in mammals is also provided by the present invention.
    Type: Grant
    Filed: April 20, 1995
    Date of Patent: July 23, 2002
    Assignee: The University of Tennessee Research Corp.
    Inventors: Linda K. Myers, Jerome M. Seyer, Andrew H. Kang
  • SYNTHETIC PEPTIDE FOR TREATMENT OF AUTOIMMUNE ARTHRITIS
    Publication number: 20020037844
    Abstract: Peptides for suppressing autoimmune arthritis by disrupting formation of trimolecular complexes which stimulate T cells.
    Type: Application
    Filed: April 20, 1995
    Publication date: March 28, 2002
    Inventors: LINDA K. MYERS, JEROME M. SEYER, ANDREW H. KANG